<DOC>
	<DOCNO>NCT01290510</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy safety TCHY106 ( 2 % hyaluronan ) treatment painful tendinopathy .</brief_summary>
	<brief_title>Hyaluronan Treatment Painful Tendinopathy</brief_title>
	<detailed_description />
	<mesh_term>Tendinopathy</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Male female patient 18 75 year age good general health condition . Signed write informed consent . Painful tendinopathy since ≥ 6 week . Pain accord Visual Analogue Scale ( VAS ; 100 millimetre ( mm ) ) ≥ 40 mm . Ensured compliance subject study period . Treatment investigational product within 4 week prior study entry . Patients know hypersensitivity product ( active compound excipients ) component procedure use study . Severe intercurrent illness ( example : uncontrolled diabetes mellitus , peripheral neuropathy ) , opinion investigator , may put patient risk participate study , affect patient 's ability take part study . Concomitant disease study relevant site influence study evaluation . List diseases characteristic judge investigator incompatible assessment and/or procedure study evaluation . List concomitant medication allow . Patients treat : systemic and/or local steroid within last 4 week , immunosuppressive drug within last 3 month , repeat use nonsteroidal antiinflammatory drug ( NSAIDs ) within last week occasional use within 24 hour . Recent history drug and/or alcohol abuse ( within last 6 month ) . List contraindication treatment . Pregnant lactating female . Fertile woman accept consistent correct use highly effective method birth control define implant , injectables , combine oral contraceptive , intrauterine device ( IUDs ) , sexual abstinence vasectomise partner treatment period first 4 week followup period . Subjects unable understand inform consent high probability non compliance study procedure non completion study accord investigator 's judgement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>tendinopathy</keyword>
	<keyword>hyaluronan</keyword>
	<keyword>tendon</keyword>
	<keyword>hyaluronic acid</keyword>
</DOC>